Tag

Praluent

All articles tagged with #praluent

Trump seals first Regeneron drug-pricing deal, pledges more savings ahead
politics2 months ago

Trump seals first Regeneron drug-pricing deal, pledges more savings ahead

President Trump announced the first round of private drug-pricing deals with Regeneron, including Medicaid price reductions, a $225 price for Praluent under TrumpRx, and a $27 billion U.S. investment in drug development; Regeneron also disclosed FDA approval of Otarmeni under a National Priority Voucher program and plans to provide it at no cost to American patients, signaling affordability efforts, though critics say the overall impact has fallen short of promises and the Otarmeni development has faced Deaf-community pushback.

Trump Admin Secures Regeneron MFN Deal to Cut Drug Costs and Boost U.S. Manufacturing
policy2 months ago

Trump Admin Secures Regeneron MFN Deal to Cut Drug Costs and Boost U.S. Manufacturing

Trump announced Regeneron’s MFN pricing deal to align U.S. prices with the lowest prices in developed nations, giving Medicaid access to MFN prices on new Regeneron medicines and cutting Praluent’s price from $537 to $225 for direct TrumpRx purchasers; all new Regeneron drugs will carry MFN pricing in the U.S. The pact also includes Otarmeni, a rare-gene therapy, provided at no cost to American families via the FDA's Priority Voucher program. Regeneron pledges $27 billion to U.S. R&D and onshore manufacturing by 2029, part of a broader push that has attracted about $448 billion in domestic pharmaceutical investments in 15 months. The administration has now secured MFN deals with 17 major manufacturers, covering roughly 86% of the branded drug market.